Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Multiple sclerosis: cladribine tablets real-world experience

Celia Oreja-Guevara • 24 May 2020
EAN 2020
Multiple Sclerosis and Related Disorders Cladribine

Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, talks on managing multiple sclerosis (MS) patients in the real world. Specifically, Dr Oreja-Guevara discusses the cladribine tablets real-world experience, including managing patients in year 2 and long-term considerations. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Celia Oreja-Guevara

The emerging role of AI in the diagnosis and management of multiple sclerosis
1:55
The emerging role of AI in the diagnosis and management of multiple sclerosis
Celia Oreja-Guevara • 29 Jun 2026
Approaches to improving the quality of life of patients with MS during the menopause
1:13
Approaches to improving the quality of life of patients with MS during the menopause
Celia Oreja-Guevara • 29 Jun 2026
EU approval of tolebrutinib marks new era in progressive multiple sclerosis
1:27
EU approval of tolebrutinib marks new era in progressive multiple sclerosis
Celia Oreja-Guevara • 29 Jun 2026
Detecting and disrupting disability accumulation in MS: a session at EAN 2026
1:57
Detecting and disrupting disability accumulation in MS: a session at EAN 2026
Celia Oreja-Guevara • 29 Jun 2026

Related Videos

What are the key changes introduced in the 2024 revision of the McDonald diagnostic criteria for MS?
6:48
What are the key changes introduced in the 2024 revision of the McDonald diagnostic criteria for MS?
Mar Tintoré • 3 Jul 2026
Ovarian aging and long-term prognosis in women with multiple sclerosis
3:07
Ovarian aging and long-term prognosis in women with multiple sclerosis
Mar Tintoré • 3 Jul 2026
The emerging role of AI in the diagnosis and management of multiple sclerosis
1:55
The emerging role of AI in the diagnosis and management of multiple sclerosis
Celia Oreja-Guevara • 29 Jun 2026
Can selected patients with multiple sclerosis safely discontinue ocrelizumab?
3:15
Can selected patients with multiple sclerosis safely discontinue ocrelizumab?
Franz Felix Konen • 28 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals